{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T03:19:28Z","timestamp":1774495168080,"version":"3.50.1"},"reference-count":45,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Mol Med"],"DOI":"10.3892\/ijmm.2017.3324","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T13:31:47Z","timestamp":1513344707000},"source":"Crossref","is-referenced-by-count":8,"title":["miR-152 is involved in the proliferation and metastasis of ovarian cancer through repression of ERBB3"],"prefix":"10.3892","author":[{"given":"Lian-Wei","family":"Li","sequence":"first","affiliation":[{"name":"Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Qi","family":"Xiao","sequence":"additional","affiliation":[{"name":"Department of General Surgery, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meng","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ge","family":"Lou","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150081, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2017,12,15]]},"reference":[{"key":"key20200713174642_b1-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"key20200713174642_b2-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"72","DOI":"10.3802\/jgo.2009.20.2.72","article-title":"Current status of gynecological cancer in China","volume":"20","author":"Kim","year":"2009","journal-title":"J Gynecol Oncol"},{"issue":"Suppl 4","key":"key20200713174642_b3-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"iv95","DOI":"10.1093\/annonc\/mdi916","article-title":"Biological characterization of ovarian cancer: prognostic and therapeutic implications","volume":"16","author":"Legge","year":"2005","journal-title":"Ann Oncol"},{"key":"key20200713174642_b4-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"212","DOI":"10.3322\/caac.20121","article-title":"Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths","volume":"61","author":"Siegel","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"key20200713174642_b5-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1016\/j.humpath.2004.03.004","article-title":"Borderline ovarian tumors: Diverse contemporary viewpoints on terminology and diagnostic criteria with illustrative images","volume":"35","author":"Seidman","year":"2004","journal-title":"Hum Pathol"},{"key":"key20200713174642_b6-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"8699","DOI":"10.1158\/0008-5472.CAN-07-1936","article-title":"MicroRNA signatures in human ovarian cancer","volume":"67","author":"Iorio","year":"2007","journal-title":"Cancer Res"},{"key":"key20200713174642_b7-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1757-2215-5-44","article-title":"Current status and implications of microRNAs in ovarian cancer diagnosis and therapy","volume":"5","author":"Zaman","year":"2012","journal-title":"J Ovarian Res"},{"issue":"Suppl 1","key":"key20200713174642_b8-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1016\/S0020-7292(06)60033-7","article-title":"Carcinoma of the ovary","volume":"95","author":"Heintz","year":"2006","journal-title":"Int J Gynaecol Obstet"},{"key":"key20200713174642_b9-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"key20200713174642_b10-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1200\/JCO.2009.24.0317","article-title":"MicroRNAs in cancer: Small molecules with a huge impact","volume":"27","author":"Iorio","year":"2009","journal-title":"J Clin Oncol"},{"key":"key20200713174642_b11-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-94-007-5590-1_1","article-title":"MicroRNAs in human cancer","volume":"774","author":"Farazi","year":"2013","journal-title":"Adv Exp Med Biol"},{"key":"key20200713174642_b12-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1126\/science.1191138","article-title":"A parsimonious model for gene regulation by miRNAs","volume":"331","author":"Djuranovic","year":"2011","journal-title":"Science"},{"key":"key20200713174642_b13-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nrc3166","article-title":"Epigenetics and genetics MicroRNAs en route to the clinic: Progress in validating and targeting microRNAs for cancer therapy","volume":"11","author":"Kasinski","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"key20200713174642_b14-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.cell.2005.06.036","article-title":"miRNAs, cancer, and stem cell division","volume":"122","author":"Croce","year":"2005","journal-title":"Cell"},{"key":"key20200713174642_b15-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/nar\/gki200","article-title":"Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis","volume":"33","author":"Cheng","year":"2005","journal-title":"Nucleic Acids Res"},{"key":"key20200713174642_b16-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1158\/0008-5472.CAN-12-3731","article-title":"Genome-wide epigenetic regulation of miRNAs in cancer","volume":"73","author":"Baer","year":"2013","journal-title":"Cancer Res"},{"key":"key20200713174642_b17-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fonc.2013.00153","article-title":"The role of microRNAs in the tumori-genesis of ovarian cancer","volume":"3","author":"Di Leva","year":"2013","journal-title":"Front Oncol"},{"key":"key20200713174642_b18-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"F77","DOI":"10.1677\/ERC-09-0203","article-title":"MicroRNAs in ovarian carcinomas","volume":"17","author":"Dahiya","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"key20200713174642_b19-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1038\/nm.2512","article-title":"miR-141 and miR-200a act on ovarian tumorigenesis by controlling oxidative stress response","volume":"17","author":"Mateescu","year":"2011","journal-title":"Nat Med"},{"key":"key20200713174642_b20-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"e2436","DOI":"10.1371\/journal.pone.0002436","article-title":"MicroRNA expression and identification of putative miRNA targets in ovarian cancer","volume":"3","author":"Dahiya","year":"2008","journal-title":"PLoS One"},{"key":"key20200713174642_b21-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.ygyno.2009.05.022","article-title":"A miR-200 microRNA cluster as prognostic marker in advanced ovarian cancer","volume":"114","author":"Hu","year":"2009","journal-title":"Gynecol Oncol"},{"key":"key20200713174642_b22-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1111\/j.1742-4658.2012.08589.x","article-title":"MicroRNA-199a targets CD44 to suppress the tumorigenicity and multidrug resistance of ovarian cancer-initiating cells","volume":"279","author":"Cheng","year":"2012","journal-title":"FEBS J"},{"key":"key20200713174642_b23-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1476-4598-7-35","article-title":"Potential role of miR-9 and miR-223 in recurrent ovarian cancer","volume":"7","author":"Laios","year":"2008","journal-title":"Mol Cancer"},{"key":"key20200713174642_b24-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1210\/me.2009-0295","article-title":"A link between mir-100 and FRAP1\/mTOR in clear cell ovarian cancer","volume":"24","author":"Nagaraja","year":"2010","journal-title":"Mol Endocrinol"},{"key":"key20200713174642_b25-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.febslet.2012.03.006","article-title":"Involvement of microRNA-93, a new regulator of PTEN\/Akt signaling pathway, in regulation of chemotherapeutic drug cisplatin chemosensitivity in ovarian cancer cells","volume":"586","author":"Fu","year":"2012","journal-title":"FEBS Lett"},{"key":"key20200713174642_b26-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1007\/s11605-010-1202-2","article-title":"Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance","volume":"14","author":"Chen","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"key20200713174642_b27-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"6450","DOI":"10.1158\/0008-5472.CAN-11-0364","article-title":"miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer","volume":"71","author":"Tsuruta","year":"2011","journal-title":"Cancer Res"},{"key":"key20200713174642_b28-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/hep.23660","article-title":"Down-regulated microRNA-152 induces aberrant DNA methylation in hepatitis B virus-related hepatocellular carcinoma by targeting DNA methyltransferase 1","volume":"52","author":"Huang","year":"2010","journal-title":"Hepatology"},{"key":"key20200713174642_b29-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1002\/pros.22656","article-title":"miR-152 controls migration and invasive potential by targeting TGF\u03b1 in prostate cancer cell lines","volume":"73","author":"Zhu","year":"2013","journal-title":"Prostate"},{"key":"key20200713174642_b30-ijmm-41-03-1529","first-page":"447","article-title":"Altered expression of miR-152 and miR-148a in ovarian cancer is related to cell proliferation","volume":"27","author":"Zhou","year":"2012","journal-title":"Oncol Rep"},{"key":"key20200713174642_b31-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1038\/nature03315","article-title":"Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs","volume":"433","author":"Lim","year":"2005","journal-title":"Nature"},{"key":"key20200713174642_b32-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"709","DOI":"10.2119\/molmed.2011.00008","article-title":"Targeting S100P inhibits colon cancer growth and metastasis by Lentivirus-mediated RNA interference and proteomic analysis","volume":"17","author":"Jiang","year":"2011","journal-title":"Mol Med"},{"key":"key20200713174642_b33-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"2691","DOI":"10.1111\/j.1582-4934.2008.00272.x","article-title":"uPA dependent and independent mechanisms of wound healing by C-phycocyanin","volume":"12","author":"Madhyastha","year":"2008","journal-title":"J Cell Mol Med"},{"key":"key20200713174642_b34-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.canlet.2014.09.029","article-title":"Next generation sequencing of pancreatic cyst fluid microRNAs from low grade-benign and high grade-invasive lesions","volume":"356","author":"Wang","year":"2015","journal-title":"Cancer Lett"},{"key":"key20200713174642_b35-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/onc.2012.575","article-title":"MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: A novel epigenetic therapy independent of decitabine","volume":"33","author":"Xiang","year":"2014","journal-title":"Oncogene"},{"key":"key20200713174642_b36-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.canlet.2012.10.026","article-title":"MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3","volume":"329","author":"Zheng","year":"2013","journal-title":"Cancer Lett"},{"key":"key20200713174642_b37-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.yexcr.2008.07.026","article-title":"ErbBs in lung cancer","volume":"315","author":"Sharma","year":"2009","journal-title":"Exp Cell Res"},{"key":"key20200713174642_b38-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrc1609","article-title":"ERBB receptors and cancer: The complexity of targeted inhibitors","volume":"5","author":"Hynes","year":"2005","journal-title":"Nat Rev Cancer"},{"key":"key20200713174642_b39-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.ceb.2008.12.010","article-title":"ErbB receptors and signaling pathways in cancer","volume":"21","author":"Hynes","year":"2009","journal-title":"Curr Opin Cell Biol"},{"key":"key20200713174642_b40-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"7692","DOI":"10.1073\/pnas.1002753107","article-title":"ErbB3\/HER3 intracellular domain is competent to bind ATP and catalyze autophosphorylation","volume":"107","author":"Shi","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200713174642_b41-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1093\/jnci\/djs501","article-title":"HER3 overexpression and survival in solid tumors: A meta-analysis","volume":"105","author":"Ocana","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"key20200713174642_b42-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"3941","DOI":"10.1158\/0008-5472.CAN-10-3775","article-title":"ErbB3 ablation impairs PI3K\/Akt-dependent mammary tumorigenesis","volume":"71","author":"Cook","year":"2011","journal-title":"Cancer Res"},{"key":"key20200713174642_b43-ijmm-41-03-1529","first-page":"973","article-title":"HER3 expression in cutaneous tumors","volume":"28","author":"Wimmer","year":"2008","journal-title":"Anticancer Res"},{"key":"key20200713174642_b44-ijmm-41-03-1529","doi-asserted-by":"publisher","first-page":"5188","DOI":"10.1158\/1078-0432.CCR-08-0186","article-title":"HER3 is a determinant for poor prognosis in melanoma","volume":"14","author":"Reschke","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20200713174642_b45-ijmm-41-03-1529","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1002\/j.1460-2075.1994.tb06577.x","article-title":"Identification of c-erbB-3 binding sites for phosphatidylinositol 3\u2032-kinase and SHC using an EGF receptor\/c-erbB-3 chimera","volume":"13","author":"Prigent","year":"1994","journal-title":"EMBO J"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T18:20:24Z","timestamp":1594664424000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2017.3324"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,15]]},"references-count":45,"URL":"https:\/\/doi.org\/10.3892\/ijmm.2017.3324","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,15]]}}}